Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA medical journals advisory panel proposed by AMA in comments on reprint guidance.

Executive Summary

FDA MEDICAL JOURNAL ADVISORY PANEL PROPOSED BY AMA in comments on FDA's December guidance to industry on dissemination of journal reprints. The American Medical Association suggests in Jan. 17 comments that FDA should allow dissemination of articles on off-label uses. As one restriction on such dissemination, AMA suggests, FDA should require that a "journal is recognized to be of national scope and reputation, as defined by an advisory panel to the FDA" with representation from national medical societies.
UsernamePublicRestriction

Register

PS027665

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel